Please login to the form below

Not currently logged in
Email:
Password:

AstraZeneca cuts 1,400 jobs

AstraZeneca is planning to close three sites across Spain, Belgium and Sweden and cut 1,400 posts as part of an efficiency drive

AstraZeneca is planning to close three sites across Spain, Belgium and Sweden and cut 1,400 posts as part of an efficiency drive. Positions will also be lost from the company's UK facility in Macclesfield.

AstraZeneca says that new manufacturing processes will enable them to drive efficiencies across the supply chain. The site closures and job cuts, which are subject to local consultation, are due to be completed by 2013.

The company is putting further investment into its plant in China where, through the enhancement of packaging and formulation capabilities, the plant will become the packing centre for Asia Pacific.

"These moves are a continuation of AstraZeneca's programme to improve the organisation's productivity and efficiency," said David Smith, executive vice president operations, AstraZeneca. "It moves the supply process closer to the customer, responding to their requirements and improving the security of the product wherever it is bought.

"I realise these changes are difficult for our affected employees, with whom we will be consulting in the coming months. We believe these changes are necessary for the long-term strength of the business."

20th November 2008

Share

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
SpotMe

SpotMe is the leading technology and service provider of enterprise engagement platforms with a focus on live events, virtual and...

Latest intelligence

Is the pharma business model ready for precision medicine?
Precision medicine promises to revolutionise patient outcomes and reduce costs for industry but is pharma ready for it? Blue Latitude Health co-founder Head of Strategy Fred Bassett explores the challenges...
ABPI2018
The NHS and ABPI at 70: inching closer to the triple win
The NHS and UK pharma’s ABPI both turn 70 this year. After years of transactional relationships, there’s a will to work more closely - but friction on prices and value...
What pharma marketers can learn from behavioural science
Pharma behavioural science and traditional emotional marketing create a powerful mix of techniques that have impact on real lives....

Infographics